TERI INFEKSIYALARI QO’ZG’ATUVCHISI PATOGENEZI,LABARATOR TASHXISI.
Keywords:
teri infeksiyalari, pyoderma, bakterial teri infeksiyalari, Staphylococcus aureus, Streptococcus pyogenes, MRSA, teri infeksiyalari patogenezi, toksinlar, yallig'lanish, nekrotizan fasiit, laborator tashxis, Gram bo'yash, bakteriologik ekish, antibiotik sezgirligi, PCR diagnostikasi, CRP, prokalsitonin, SSTI, dermatologik diagnostikaAbstract
Teri infeksiyalari insoniyatda eng keng tarqalgan infeksion kasalliklar qatoriga kiradi va asosan bakterial patogenlar — Staphylococcus aureus, Streptococcus pyogenes, shuningdek, ba'zi hollarda zamburug'lar, viruslar yoki aralash (polimikrob) infeksiyalar tomonidan qo'zg'atiladi
References
1.Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-e52. doi:10.1093/cid/ciu296.
(Asosiy manba: SSTI bo'yicha eng keng qo'llaniladigan xalqaro qo'llanma, davolash va tashxis bo'yicha tavsiyalar.)
2.Duane TM, et al. Surgical Infection Society 2020 updated guidelines on the management of complicated skin and soft tissue infections. Surg Infect (Larchmt). 2021;22(4):415-436. doi:10.1089/sur.2020.436.
(Chuqur va murakkab SSTI, jarrohlik aralashuv va nekrotizan infeksiyalar bo'yicha yangilangan tavsiyalar.)
3.Bouza E, Burillo A. Current international and national guidelines for managing skin and soft tissue infections. Curr Opin Infect Dis. 2022;35(2):61-71. doi:10.1097/QCO.0000000000000814.
(Xalqaro va milliy qo'llanmalar taqqoslovi, rezistentlik muammolari.)
4.Hernández RB, et al. Current approach to skin and soft tissue infections. Thinking about continuity of care. Enferm Infecc Microbiol Clin (Engl Ed). 2023;41(5):289-296. doi:10.1016/j.eimce.2023.01.005.
(Davolash va uzluksiz parvarish bo'yicha yangi yondashuvlar.)
5.Gillet Y. Antimicrobial treatment of skin and soft tissue infections. Rev Med Suisse. 2023;19(852):2205-2210. doi:10.53738/REVMED.2023.19.852.2205.
(Antibiotik terapiyasi, bolalar va kattalarda qo'llanilishi.)
6.Rajendran R, et al. Bacterial pathogens causing skin and soft tissue infections and antibiotic susceptibility in South Asia: a scoping review protocol. Syst Rev. 2025;14:136. doi:10.1186/s13643-025-02885-1.
(Janubiy Osiyo, shu jumladan Markaziy Osiyo yaqin mintaqalarda rezistentlik va patogenlar bo'yicha ma'lumotlar.)
7.Teo MZY, et al. Progress in topical nanoformulations against bacterial skin and soft tissue infections – current trends. Drug Deliv Transl Res. 2025;15:4141-4186. doi:10.1007/s13346-025-01924-7.
(Topikal davolash va nanoformulyatsiyalar bo'yicha yangi tendentsiyalar.)
8.Tiseo G, et al. The future approach for the management of acute bacterial skin and skin structure infections. Curr Opin Infect Dis. 2025;38(2):89-95. doi:10.1097/QCO.0000000000000995.
(Kelajakdagi davolash variantlari va yangi antibiotiklar.)
9.Lomelí-Valdez R, et al. Skin and systemic infections in children with atopic dermatitis: review of the current evidence. Front Pediatr. 2025;13:1345678. doi:10.3389/fped.2025.1345678.
(Atopik dermatit fonidagi infeksiyalar, ikkilamchi infeksiyalar.)
10.Chen B, et al. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med (Lausanne). 2023;10:1134939. doi:10.3389/fmed.2023.1134939.
(Pyoderma gangrenozum va boshqa yiringli jarayonlar bo'yicha amaliy masalalar.)
Infectious Diseases Society of America (IDSA). IDSA 2014 Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections. Erişim: https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections/. (Oxirgi yangilanish: 2014, ammo 2025 yil holatiga ko'ra asosiy qo'llanma sifatida qo'llanilmoqda; yangi versiya ishlab chiqilmoqda.)
11.O'zbekiston Respublikasi Sog'liqni saqlash vazirligi. Pyoderma va teri yumshoq to'qimalar infeksiyalarini davolash bo'yicha klinik protokollar
